NCT00452868 · OUTCOME

Neurocognitive Function as Measured by the Neurocognitive Battery at 24 Weeks

Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain · Source last updated 2018-09-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEAN
Unit: units on a scale
Interval / dispersion: Standard Deviation
Time frame: 24 weeks

What was measured

Delis-Kaplan Executive Function System Tower Total Scaled Score, range is 1-19 with the higher score being a better outcome.

Groups in this outcome

Donepezil

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Donepezil	11

Reported measurements

Source class 1

Values in units on a scale · Interval/dispersion: Standard Deviation
Group	Value	Spread	Lower	Upper	Comment
Donepezil	10	3	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
spread
3
value
10

denoms

counts
group Id
OG000
value
11
units
Participants

description

Delis-Kaplan Executive Function System Tower Total Scaled Score, range is 1-19 with the higher score being a better outcome.

dispersion Type

Standard Deviation

groups

id
OG000
title
Donepezil

param Type

MEAN

reporting Status

POSTED

time Frame

24 weeks

title

Neurocognitive Function as Measured by the Neurocognitive Battery at 24 Weeks

type

PRIMARY

unit Of Measure

units on a scale

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice